View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development



When: June 16, 2021, 12 p.m. ET

Case Study: Modeling disease progression in polycystic kidney disease to inform trial design

Presenters: Rhoda Muse, PhD, Scientist 1, Quantitative Medicine; Klaus Romero, MD, MS, FCP, Chief Science Officer and Executive Director of Clinical Pharmacology; Jackson Burton, PhD, Executive Director, Quantitative Medicine

RDCA-DAP Team: Jeff Barrett, PhD, FCP., Senior Vice President, RDCA-DAP Lead; Alexandre Bétourné, PhD, PharmD, Scientific Director, RDCA-DAP


View Now


This event is part of a new webinar series, for additional webinars visit